Our goal is to design new medicines using quantum computing inspired generative AI drug discovery platform. Through the maximal utilization of AI in refining
Errungenschaften
Team
Prototyp
Nutzer
Partner
Umsätze
Investoren
Unser Angebot
We are a digital biotech startup in cell & gene therapy focussed precious therapeutics company inspired by artificial intelligence (Quantum Deep Learning) technology.
Our Generative AI model running (quantum computing) to design protein from scratch to identify the undruggable targets in the oncology, autoimmune disease & ophthalmology.
Zielgruppe
Our platform utilizes deep generative machine learning models with quantum computing trained on vast datasets of molecular structures, biological data, and clinical outcomes to predict drug-target interactions, identify potential candidates, and optimize drug design.
Herausforderungen
Predictive Modeling - This model predicts the efficacy and safety of potential drug compounds with high accuracy.
Virtual Screening - Rapidly screens millions of compounds to identify best candidate.
Optimization Algorithms - Optimizes drug properties to enhanced efficacy candidate.
Continuous Learning - Constantly learns from new data to improve predictions.
Unsere Story
Hauptsitz
Weitere Startups
Diese Gründungsprojekte könnten auch interessant für Dich sein!
